戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1373533作成日:2026年10月26日

Sodium triacetoxyborohydride → 7-{4-[4-(5-Chloro-2-isopropoxy-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-one

https://huagongshe.com/reaction/1373533

反応式

関与物質

役割名称HCID仕込み量
反応物Sodium triacetoxyborohydrideHCID 5049666—
反応物1-(5-Chloro-2-isopropoxy-phenyl)-piperazineHCID 21073166—
反応物4-((7-Oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)oxy)butanalHCID 21073377—
溶媒1,1-DichloroethaneHCID 6365—
溶媒Ethyl AcetateHCID 8857—
生成物7-{4-[4-(5-Chloro-2-isopropoxy-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-oneHCID 2107371145.4%

反応手順

To a suspension of 4-(7-oxo-5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yloxy)-butyraldehyde (0.241 g, 1.02 mmol, 1 eq) and 1-(5-chloro-2-isopropoxy-phenyl)-piperazine (0.382 g, 1.13 mmol, 1.1 eq) in dichloroethane (5 mL) was added NaBH(OAc)3 (0.583 g, 2.75 mmol, 2.67 eq). The slurry was allowed to stir overnight at room temperature (18 h). Analysis by HPLC showed reaction mostly complete. The mixture was diluted with EtOAc and quenched with saturated NaHCO3. The organic phase was then washed with brine, dried over Na2SO4, filtered and evaporated in vacuo. Purification by silica gel chromatography (100% EtOAc) followed by formation of the HCl salt using 1N HCl in ether provided the title compound (0.219 g, 25%). MS: APCI: M+1: 473.2 (Exact Mass: 472.22).

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US07160888B2
出典データセットuspto-grants-2007_01
ORD IDord-dd37439ed99643c7a02d08a9e358a307
出典メモuspto-grants-2007_01